相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Avastin Doesn't Blind People, People Blind People
Serafin Gonzalez et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
Tim U. Krohne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
An Outbreak of Streptococcus Endophthalmitis After Intravitreal Injection of Bevacizumab
Roger A. Goldberg et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
Maria Salling Eghoj et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Embryonic stem cell trials for macular degeneration: a preliminary report
Steven D. Schwartz et al.
LANCET (2012)
The Expanding Role of Vascular Endothelial Growth Factor Inhibitors in Ophthalmology
Michael W. Stewart
MAYO CLINIC PROCEEDINGS (2012)
HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Michael A. Singer et al.
OPHTHALMOLOGY (2012)
Age and Gender Variations in Age-related Macular Degeneration Prevalence in Populations of European Ancestry: A Meta-analysis
Alicja R. Rudnicka et al.
OPHTHALMOLOGY (2012)
The Age-related Eye Disease Study 2 (AREDS2) Study Design and Baseline Characteristics (AREDS2 Report Number 1)
Emily Y. Chew et al.
OPHTHALMOLOGY (2012)
Investigation of the role of neutralizing antibodies against bevacizumab as mediators of tachyphylaxis
Farzin Forooghian et al.
ACTA OPHTHALMOLOGICA (2011)
Pharmacotherapy for Neovascular Age-Related Macular Degeneration: An Analysis of the 100% 2008 Medicare Fee-For-Service Part B Claims File
Ross J. Brechner et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment
Y. Wang et al.
EYE (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials
Philip J. Rosenfeld et al.
OPHTHALMOLOGY (2011)
Age related macular degeneration and drusen: Neuroinflammation in the retina
Elisa Buschini et al.
PROGRESS IN NEUROBIOLOGY (2011)
Review of Combination Therapies for Neovascular Age-Related Macular Degeneration
Steven M. Couch et al.
SEMINARS IN OPHTHALMOLOGY (2011)
Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
P. Mitchell et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2010)
Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study
Adnan Tufail et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
ω-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study
John Paul SanGiovanni et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Forecasting Age-Related Macular Degeneration Through the Year 2050 The Potential Impact of New Treatments
David B. Rein et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration
James A. Dixon et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Inflammation and the pathogenesis of age-related macular degeneration
Albert J. Augustin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Antiangiogenic Approaches to Age-Related Macular Degeneration Today
Neil M. Bressler
OPHTHALMOLOGY (2009)
Cerebrovascular Accidents in Ranibizumab
Takashi Ueta et al.
OPHTHALMOLOGY (2009)
A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration
David S. Boyer et al.
OPHTHALMOLOGY (2009)
Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans
Tim U. Krohne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Predicted biological activity of intravitreal VEGF trap
M. W. Stewart et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
L. J. Singerman et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Ex vivo dynamic imaging of retinal microglia using time-lapse confocal microscopy
Jung Eun Lee et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Age-related macular degeneration
Hanna R. Coleman et al.
LANCET (2008)
Medical progress: Age-related macular degeneration
Rama D. Jager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Is There Tachyphylaxis to Intravitreal Anti-Vascular Endothelial Growth Factor Pharmacotherapy in Age-Related Macular Degeneration?
Shlomit Schaal et al.
OPHTHALMOLOGY (2008)
Dietary antioxidants and the long-term incidence of age-related macular degeneration - The Blue Mountains Eye Study
Jennifer S. L. Tan et al.
OPHTHALMOLOGY (2008)
Pharmacokinetics of intravitreal ranibizumab (Lucentis)
Sophie J. Bakri et al.
OPHTHALMOLOGY (2007)
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
Uwe-Karsten Hanisch et al.
NATURE NEUROSCIENCE (2007)
Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with Neovascular age-related macular degeneration
Rajendra S. Apte
OPHTHALMOLOGY (2007)
Fifteen-year cumulative incidence of age-related macular degeneration
Ronald Klein et al.
OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mechanisms of disease: Age-related macular degeneration
Paulus T. V. M. de Jong
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration
Napoleone Ferrara et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension - TAP Report No. 8
Peter K. Kaiser
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2006)
Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the carotenoids in age-related eye disease study (CAREDS) - Ancillary study of the women's health initiative
Suzen M. Moeller et al.
ARCHIVES OF OPHTHALMOLOGY (2006)
Six-month stability of bevacizumab (avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing
Sophie J. Bakri et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
B Gold et al.
NATURE GENETICS (2006)
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
RL Avery et al.
OPHTHALMOLOGY (2006)
Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: Results of a phase I clinical trial
PA Campochiaro et al.
HUMAN GENE THERAPY (2006)
Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation
JC Khan et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Dietary intake of antioxidants and risk of age-related macular degeneration
R van Leeuwen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Neovascular age-related macular degeneration - Natural history and treatment outcomes
D Pauleikhoff
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2005)
Risk factors for the incidence of advanced age-related macular degeneration in the age-elated eye disease study (AREDS) - AREDS report no.19
RC Milton et al.
OPHTHALMOLOGY (2005)
The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina
JP SanGiovanni et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2005)
Managing patients treated with bevacizumab combination therapy
MS Gordon et al.
ONCOLOGY (2005)
Smoking and age-related macular degeneration: a review of association
J Thornton et al.
EYE (2005)
Perceptions of blindness related to smoking: a hospital-based cross-sectional study
G Bidwell et al.
EYE (2005)
The epidemiology of age-related macular degeneration
R Klein et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Risks of intravitreous injection: A comprehensive review
RD Jager et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2004)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Autophagy in health and disease: A double-edged sword
T Shintani et al.
SCIENCE (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Associations of visual function with physical outcomes and limitations 5 years later in an older population - The Beaver Dam eye study
BEK Klein et al.
OPHTHALMOLOGY (2003)
Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration
N Gupta et al.
EXPERIMENTAL EYE RESEARCH (2003)
Progression of age-related macular degeneration - Association with dietary fat, transunsaturated fat, nuts, and fish intake
JM Seddon et al.
ARCHIVES OF OPHTHALMOLOGY (2003)
Role of vascular endothelial growth factor in Physiologic and Pathologic angiogenesis: Therapeutic implications
N Ferrara
SEMINARS IN ONCOLOGY (2002)
Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes
A Otani et al.
MICROVASCULAR RESEARCH (2002)
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration
GS Hageman et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2001)
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No. 8
A Kassoff et al.
ARCHIVES OF OPHTHALMOLOGY (2001)
Lutein, zeaxanthin, and the macular pigment
JT Landrum et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
分享论文
